GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Study Links Epigenetic Aging and Telomere Shortening to Cognitive Impairments in Childhood Cancer Survivors

by GOAI
Share To

A recent study published in *Nature Communications* examines the relationship between epigenetic aging, telomere dynamics, and neurocognitive function in long-term survivors of childhood cancer. Researchers investigated how these biological factors may contribute to premature aging phenotypes frequently observed in this population. The findings provide insight into potential mechanisms underlying cognitive challenges and accelerated aging among individuals who have survived pediatric cancers.

The study highlights the role of epigenetic changes and telomere shortening, which are markers often associated with aging, in survivors of childhood cancer. Researchers analyzed data from participants who had undergone treatment for various types of pediatric cancers and assessed their neurocognitive performance alongside biological indicators of aging. The results suggest that disruptions in normal epigenetic processes and telomere maintenance may be linked to cognitive impairments seen in this group. These findings add to growing evidence about the long-term health impacts faced by childhood cancer survivors and offer a deeper understanding of how their biology may influence cognitive outcomes later in life.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top